| Date Filed | Type | Description |
| 07/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2023 |
4
| THOMPSON VIRGIL (Director) has filed a Form 4 on Processa Pharmaceuticals, Inc.|
Txns:
| Exercised 18,208 shares
@ $0
Granted 30,000 restricted stock units
@ $0 |
|
| 08/09/2022 |
4
| THOMPSON VIRGIL (Director) has filed a Form 4 on Processa Pharmaceuticals, Inc.|
Txns:
| Exercised 1,169 shares
@ $0 |
|
| 04/19/2022 |
4
| THOMPSON VIRGIL (Director) has filed a Form 4 on Processa Pharmaceuticals, Inc.|
Txns:
| Granted 18,208 restricted stock units
@ $0 |
|
| 04/04/2022 |
4
| THOMPSON VIRGIL (Director) has filed a Form 4 on Processa Pharmaceuticals, Inc.|
Txns:
| Granted 4,393 shares
@ $0 |
|
| 08/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/02/2020 |
3
| THOMPSON VIRGIL (Director) has filed a Form 3 on Processa Pharmaceuticals, Inc. |
| 07/03/2018 |
4
| THOMPSON VIRGIL (Director) has filed a Form 4 on ARADIGM CORP|
Txns:
| Granted 97,323 options to buy
@ $1.45, valued at
$141.1k
|
|
| 06/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/13/2016 |
4
| THOMPSON VIRGIL (Director) has filed a Form 4 on ARADIGM CORP|
Txns:
| Granted 35,941 options to buy
@ $4.48, valued at
$161k
|
|
| 11/16/2015 |
4
| THOMPSON VIRGIL (Director) has filed a Form 4 on ARADIGM CORP|
Txns:
| Granted 19,940 options to buy
@ $6.5, valued at
$129.6k
|
|
| 04/22/2014 |
4
| THOMPSON VIRGIL (Director) has filed a Form 4 on ARADIGM CORP|
Txns:
| Granted 225,000 options to buy
@ $0.22, valued at
$49.5k
|
|
| 12/16/2013 |
4
| THOMPSON VIRGIL (Director) has filed a Form 4 on ARADIGM CORP|
Txns:
| Sold 3,340 shares
@ $0.17, valued at
$567.8
Exercised 10,000 options to buy
@ $0.16, valued at
$1.6k
Sold 3,340 shares
@ $0.17, valued at
$567.8
Exercised 10,000 options to buy
@ $0.16, valued at
$1.6k
|
|
| 12/05/2013 |
4
| THOMPSON VIRGIL (Director) has filed a Form 4 on SAVIENT PHARMACEUTICALS INC|
Txns:
| Sold 106,751 shares
@ $0.023, valued at
$2.5k
|
|
| 06/24/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/30/2012 |
4
| THOMPSON VIRGIL (Director) has filed a Form 4 on ARADIGM CORP|
Txns:
| Granted 166,667 shares
@ $0
Granted 140,000 options to buy
@ $0.15, valued at
$21k
|
|
| 05/24/2012 |
4
| THOMPSON VIRGIL (Director) has filed a Form 4 on SAVIENT PHARMACEUTICALS INC|
Txns:
| Granted 49,382 shares
@ $0.81, valued at
$40k
Granted 69,728 options to buy
@ $0.81, valued at
$56.5k
|
|
| 06/24/2011 |
4
| THOMPSON VIRGIL (Director) has filed a Form 4 on SOLIGENIX, INC.|
Txns:
| Granted 191,722 options to buy
@ $0.199, valued at
$38.2k
|
|
| 06/01/2011 |
4
| THOMPSON VIRGIL (Director) has filed a Form 4 on ARADIGM CORP|
Txns:
| Granted 131,579 shares
@ $0
Granted 100,000 options to buy
@ $0.19, valued at
$19k
|
|
| 05/31/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/27/2010 |
4
| THOMPSON VIRGIL (Director) has filed a Form 4 on SOLIGENIX, INC.|
Txns:
| Granted 300,000 options to buy
@ $0.205, valued at
$61.5k
|
|
| 09/27/2010 |
3
| THOMPSON VIRGIL (Director) has filed a Form 3 on SOLIGENIX, INC. |
| 09/07/2010 |
4
| THOMPSON VIRGIL (Director) has filed a Form 4 on SAVIENT PHARMACEUTICALS INC|
Txns:
| Exercised 7,500 options to buy
@ $11.813, valued at
$88.6k
|
|
| 07/21/2010 |
4/A
| Form 4 - Statement of changes in beneficial ownership of securities [amend] |
| 06/10/2010 |
4
| THOMPSON VIRGIL (Director) has filed a Form 4 on SAVIENT PHARMACEUTICALS INC|
Txns:
| Granted 3,514 shares
@ $11.38, valued at
$40k
Granted 4,831 options to buy
@ $11.38, valued at
$55k
|
|
| 05/18/2010 |
4
| THOMPSON VIRGIL (Director) has filed a Form 4 on ARADIGM CORP|
Txns:
| Granted 208,333 shares
@ $0
Granted 100,000 options to buy
@ $0.12, valued at
$12k
|
|
| 06/04/2009 |
4/A
| THOMPSON VIRGIL (Director) has filed a Form 4 on ARADIGM CORP |
| 05/20/2009 |
4
| THOMPSON VIRGIL (Director) has filed a Form 4 on ARADIGM CORP |
| 05/13/2009 |
4
| THOMPSON VIRGIL (Director) has filed a Form 4 on SAVIENT PHARMACEUTICALS INC |